Clinical trial NCT05662046: Deformity of the Forefoot in Children With Unilateral Cerebral Palsy
Official title: Deformity of the Forefoot in Children With Unilateral Cerebral Palsy
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Forefoot Adductus
Cerebral Palsy
Keywords: Cerebral Palsy
Forefoot Deformity
Lead sponsor: University Hospital, Brest
Sponsor class: OTHER
First posted: 2022-12-22
Enrollment: 52
Sex: ALL
Minimum age (years): 2
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Walking child with unilateral Cerebral Palsy who benefit of a 3D Motion Analysis on the motion analysis laboratory in Brest, France, between august 2012 and may 2017.

Brief summary: Midfoot and backfoot deformities are well described in children with Cerebral palsy. However, data regarding forefoot deformities in Cerebral palsy remain scarce in a population were foot deformities are the most frequent musculo-skeletal deformities.

Detailed description: Foot deformities are the most frequent musculo-skeletal deformities in children with Cerebral palsy. Pain starts in the foot, especially during gait in Cerebral Palsy Children (GMFCS I and II) and induce gait limitations, balance disorders, wounds, aesthetic disorders and difficulties to support shoes.

Metatarsus Adductus is the most common foot deformity in children with or without disorder, occuring on 1-2/1000 births. In 4 to 14% of the children, evolution is not favorable at 5 years. In that case, the diagnostic of Cerebral palsy have to be considered.

Eligibility criteria: Inclusion Criteria:

* Child who benefit a standardised clinical evaluation before a 3D Gait Analysis with forefoot deformity measure
* Child age less than 18 years old
* Child with left or right unilateral cerebral palsy
* Walking child ( GMFCS score I, II or III)
* In case of several 3D Gait Analysis for the child: the 3D gait analysis was chosen first before any local spasticity treatment with botulinic toxin injection or the 3D gait evaluation the more far from local spastica treatment with botulinic toxin injection was chosen in second .

Exclusion Criteria:

* Hemiplegia due to another etiology
* History of lower limb or foot surgery before the clinical evaluation
* Local spasticy treatment with botulinic toxin injection less than 3 months before the clinical evaluation
* Participation refusal

Primary outcomes:
measure: Measure of the forefoot deformity prevalence in plegia and non-plegia foot during gait in unilateral cerebral palsy children
timeFrame: 1 day
Secondary outcomes:
measure: Anthropometric factors (age) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: Anthropometric factors (sexe) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: Anthropometric factors (type of cerebral palsy)associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: functional factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: biomechanical osteoarticular factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: Spasticity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
measure: Motricity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.
timeFrame: 1 day
Other outcomes:
Locations:
city: Brest
country: France
facility: Houx
city: Concarneau
country: France
facility: PRIGENT
Study officials:
References: